Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it.

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

The following is a summary of “An exploratory analysis of differences in serum protein expression by sex in patients with ...

Interstitial lung disease (ILD) is a broad term for a group of conditions that cause lung inflammation and/or fibrosis (scarring ... is a thin layer of connective tissue that supports your ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar ...

Fibrosis refers to aberrant connective tissue that accumulates ... emerging in the lungs as idiopathic pulmonary fibrosis, or in the liver as fatty liver disease. Kidney and cardiac fibrosis ...

the part connective tissue growth factor might play in fibrotic disease. Objective: The aim of this study was to evaluate pulmonary function in patients suffering from scleroderma treated for 3 ...

South Korean researchers have developed a new technology that can recognize and detect lung diseases such as Chronic Obstructive Pulmonary ... to help prevent fibrosis, scar tissue that interferes ...

Bristol-Myers Squibb (BMS) has been steadily building its position in fibrotic diseases ... FibroGen's connective tissue growth factor (CTGF) blocker FG-3019. Pharma's interest in fibrosis stems ...